Return of BioPharm America™ 2013 to Boston will draw leading international life science dealmakers to Northeast
EBD Group, the leading partnering firm for the life science industry, in collaboration with the Massachusetts Biotechnology Council (MassBio) announced today that BioPharm America™ 2013 will again be held in Boston September 17–19 at the Westin Boston Waterfront in Boston, MA.
Senior executives from big pharma are set to attend, including AstraZeneca, Bayer HealthCare, EMD Serono, Janssen, Merck, Novo Nordisk, Shire, and more. Program topics cover trends in healthcare and drug development and other timely issues for industry insiders. Spotlight panels and roundtables will also feature industry leaders in discussions on innovative partnerships, emerging markets and global drug development strategies. The 2012 edition welcomed over 750 delegates representing 462 companies from 30 countries. Delegates in 2012 engaged in 1,846 one-to-one partnering meetings with 652 licensing opportunities.
“Boston is a biotechnology innovation hub. There are more than 500 companies focused on pharmaceutical and biotech drug discovery located in Massachusetts, from small start-ups to large established pharmaceuticals,” said Carola Schropp, President of EBD Group. “This creates an ideal environment for partnering, and is what draws the global biotech sector to BioPharm America.”
“At MassBio, our focus is to promote world class biotechnology in Massachusetts, and BioPharm America is the forum that enables regional biotech companies to identify and enter into strategic relationships at the global level,” said Robert Coughlin, President and CEO of MassBio. “The partnering at BioPharm America, and particularly the process of meeting face-to-face to discuss novel assets, is a definite advantage in the culmination of any deal.”
BioPharm America 2013 will again celebrate the announcement of the Fierce 15, selected for their pioneering technology and innovative business models, with John Carroll, Editor-in-Chief of FierceBiotech, featured on a panel with several Fierce 15 CEOs to discuss the industry outlook for the life sciences.
One-to-one networking at BioPharm America™ is powered by partneringONE®, the leading conference networking solution for the life sciences.
Register before July 19, 2013 to save USD 200 atwww.ebdgroup.com/bpa/registration/index.php
MassBio members receive an additional USD 200 discount by adding the code ‘MassBio‘ in the comments field of the online registration form.
Presenting companies should submit an application by June 28, 2013 atwww.ebdgroup.com/bpa/presenters/index.php
Notes to Editors:
Entry to BioPharm America 2013 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BioPharm America conference website atwww.ebdgroup.com/bpa/registration/press_reg.php for press registration details. In addition, Business Wire, the official News Release Distribution and Online Press Kit service for BioPharm America™ 2013, is offering services to enhance your public relations efforts.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
About BioPharm America 2014
BioPharm America is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.
Additional links and information:
Follow BioPharm America 2014 on Twitter: twitter.com/ebdgroup (hashtag: #BPA14)
Or join the Life Science Partnering group on partnering360® to kick off your partnering activities before BioPharm America, and throughout the year. partnering360 is a dynamic network of life science industry experts that will enable you to continue the dialogue from your partneringONE meetings at events and identify and connect with new partners anytime, year-round. Join the vibrant community of life science companies on partnerning360 today.